After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Beam Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
BEAM belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Beam Therapeutics Inc is $2.59B. A total of 0.8 million shares were traded on the day, compared to an average of 1.32M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, BEAM has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 29,549 shares. Over the last 12 months, there were 12 BUYs and 17 SELLs from insiders. Insiders purchased 339,931 shares during that period but sold 228,463.
In the most recent transaction, FMR LLC sold 900,000 shares of BEAM for 30.55 per share on Feb 14. After the transaction, the See Remark 1 now owns 1,235,511 company shares. In a previous transaction on Feb 13, FMR LLC sold 1,565 shares at 30.76 per share. BEAM shares that See Remark 1 owns now total 2,771,913.
Among the insiders who sold shares, Evans John M. disposed of 60,000 shares on Jan 31 at a per-share price of $25.33. This resulted in the CEO holding 1,058,262 shares of BEAM after the transaction. In another insider transaction, Bellon Christine sold 1,907 shares at $26.42 per share on Jan 03. Company shares held by the Chief Legal Officer now total 80,495.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for BEAM in the last 3 months, the mean price target is $45.54 with high estimates of $78.00 and low estimates of $19.00. In terms of 52-week highs and lows, BEAM has a high of $42.15 and a low of $16.95.
As of this writing, BEAM has an earnings estimate of -$1.01 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $1.21 per share and a lower estimate of -$1.46. The company reported an EPS of -$1.08 in the last quarter, which was 23.90% higher than expectations of -$1.42.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BEAM’s latest balance sheet shows that the firm has $965.65M in Cash & Short Term Investments as of fiscal 2021. There were $142.35M in debt and $213.44M in liabilities at the time. Its Book Value Per Share was $9.81, while its Total Shareholder’s Equity was $826.74M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BEAM is Buy with a score of 4.07.
